Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,236,342
+$469,652 QoQ
Shares Held
12,861
+1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,596
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. ABBV ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
|
2,000 | $432,120 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,236,342 | 12,861 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,766,690 | 12,721 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,906,621 | 12,721 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,001,453 | 12,963 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,434,963 | 13,118 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,850,100 | 13,603 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,637,601 | 14,843 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,016,112 | 15,273 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,662,504 | 15,523 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,826,738 | 15,523 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,405,599 | 15,523 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,383,469 | 15,990 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,266,428 | 16,822 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,680,922 | 16,822 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,718,603 | 16,822 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,264,391 | 16,872 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,636,189 | 17,212 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,708,858 | 16,710 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,516,273 | 18,584 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,005,842 | 18,595 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,289,295 | 20,324 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,621,845 | 24,227 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,595,601 | 24,224 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,704,326 | 19,458 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $834,530 | 8,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $647,157 | 8,494 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||